FDA Clearance Tracker · P070026-S061
Ceramax Ceramic Total Hip System
Last checked: Nov 20, 2026Latest source record: Oct 27, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Oct 27, 2019
Approved
Time to decision
164 days
Received May 16, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P070026-S061
- Device name
- Ceramax Ceramic Total Hip System
- Applicant
- DePuy Orthopaedics, Inc.
- Applicant location
- Warsaw, IN
- Received
- May 16, 2019
- Decided
- Oct 27, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P070026
Device type
- Device type
- Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at for a manufacturing site located at Synergy Health Westport Ltd., Lodge Road, Westport Mayo, Ireland for the for terminal gamma irradiation sterilization of the Summit Hip Stems
Source documents
Other decisions for DePuy Orthopaedics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262130 · Decided Sep 4, 2026 · 72 days after receipt
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (JWH) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.